Free Trial

OS Therapies (OSTX) Stock Chart & Stock Price History

OS Therapies logo
$1.74 -0.03 (-1.69%)
(As of 11/20/2024 ET)

OS Therapies Stock Price Performance

5 Day
Performance
-20.91%
1 Month
Performance
-41.81%
3 Month
Performance
-56.50%
Receive OSTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OS Therapies and its competitors with MarketBeat's FREE daily newsletter.

OSTX Stock Chart for Thursday, November, 21, 2024

OS Therapies Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
11/20/2024$1.77$1.74
-1.69%
$1.84$1.6766,704 shs$36.96 million
11/19/2024$2.06$1.77
-14.08%
$2.18$1.5866,466 shs$37.60 million
11/18/2024$2.20$2.06
-6.36%
$2.34$2.0626,485 shs$43.75 million
11/15/2024$2.20$2.20$2.50$2.1022,472 shs$44.11 million
11/14/2024$2.52$2.20
-12.70%
$2.76$2.1442,902 shs$44.11 million
11/13/2024$2.63$2.52
-4.18%
$2.79$2.5057,568 shs$50.53 million
11/12/2024$2.59$2.63
+1.54%
$2.87$2.608,446 shs$52.73 million
11/11/2024$2.85$2.59
-9.12%
$2.88$2.5512,388 shs$51.93 million
11/08/2024$2.81$2.80
-0.36%
$2.94$2.6712,429 shs$56.14 million
11/07/2024$2.75$2.81
+2.18%
$2.85$2.775,425 shs$56.34 million
11/06/2024$2.62$2.75
+4.96%
$2.78$2.6712,826 shs$55.14 million
11/05/2024$2.65$2.62
-1.13%
$2.71$2.6012,353 shs$52.53 million
11/04/2024$2.63$2.65
+0.76%
$2.73$2.6110,342 shs$53.13 million
11/01/2024$2.67$2.74
+2.81%
$2.88$2.6310,348 shs$54.94 million
10/31/2024$2.55$2.67
+4.51%
$2.79$2.6217,152 shs$53.43 million
10/30/2024$2.66$2.55
-4.03%
$2.72$2.5539,716 shs$51.13 million
10/29/2024$2.91$2.66
-8.69%
$2.94$2.6617,991 shs$53.27 million
10/28/2024$2.86$2.91
+1.75%
$2.99$2.8715,865 shs$58.35 million
10/25/2024$2.92$2.86
-2.05%
$3.02$2.8613,079 shs$57.34 million
10/24/2024$2.99$2.92
-2.34%
$3.06$2.9220,514 shs$58.55 million
10/23/2024$3.00$2.99
-0.33%
$3.05$2.9410,749 shs$59.95 million
10/22/2024$2.99$3.00
+0.33%
$3.12$2.9221,136 shs$60.15 million
10/21/2024$3.02$2.99
-0.89%
$3.13$2.9923,802 shs$59.95 million


This page (NYSE:OSTX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners